Healthcare Sector

Members of Parliament invested in the Healthcare Sector

156 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£137.93	218.99%	£223,290.91
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£137.93	199.00%	£209,301.96
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£13,980.00	16.27%	£81,387.23
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£13,980.00	239.65%	£237,755.10
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£13,980.00	260.63%	£252,444.22
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£13,980.00	88.36%	£131,851.25
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£13,980.00	18.74%	£83,115.34
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£13,980.00	424.28%	£366,997.94
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£13,980.00	15.00%	£80,503.46
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£13,980.00	158.08%	£180,653.50
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£13,980.00	17.24%	£82,069.78
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£13,980.00	36.66%	£95,659.82
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£13,980.00	74.64%	£122,248.59
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£13,980.00	375.83%	£333,083.73
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£1.07	-67.67%	£22,628.40
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£59.17	58.25%	£110,775.61
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£59.17	10.74%	£77,520.12
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£59.17	38.31%	£96,818.61
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£59.17	50.25%	£105,177.75
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£59.17	39.85%	£97,894.11
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£59.17	49.84%	£104,884.77
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£59.17	32.22%	£92,556.42
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£59.17	34.42%	£94,091.32
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£59.17	58.34%	£110,834.89
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£237.79	44.09%	£100,862.27
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£237.79	93.89%	£135,724.88
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£237.79	227.13%	£228,990.22
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£237.79	290.27%	£273,187.26
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£237.79	47.04%	£102,926.66
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£215.75	199.01%	£209,308.50
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£215.75	-13.31%	£60,681.13
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£268.55	6.05%	£74,237.81
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£268.55	-45.20%	£38,359.59
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£268.55	-50.07%	£34,952.49
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£268.55	-48.18%	£36,276.53
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£268.55	-54.82%	£31,626.01
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,382.85	105.63%	£143,941.92
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£542.36	29.71%	£90,795.42
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£542.36	18.10%	£82,669.63
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£542.36	-7.07%	£65,049.00
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£542.36	17.13%	£81,991.18
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£542.36	13.60%	£79,523.26
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£146.20	-76.13%	£16,705.84
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£146.20	-54.31%	£31,981.25
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£43.34	19.23%	£83,460.80
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£43.34	-57.38%	£29,833.81
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£43.34	-64.69%	£24,715.28
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£43.34	-67.82%	£22,529.33
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£126.73	-24.61%	£52,772.75
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£126.73	-22.17%	£54,484.09
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£153.95	74.19%	£121,933.70
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£153.95	133.09%	£163,160.68
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£153.95	184.88%	£199,412.60
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£202.00	-11.21%	£62,153.85
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£358.70	42.43%	£99,698.23
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£358.70	15.84%	£81,088.33
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£358.70	40.23%	£98,158.72
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£358.70	18.38%	£82,867.99
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£358.70	16.08%	£81,258.90
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£109.08	331.72%	£302,205.30
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£109.08	0.24%	£70,167.25
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£109.08	231.55%	£232,085.10
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£16.08	-84.11%	£11,122.53
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£26.49	35.54%	£94,875.35
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£26.49	-8.73%	£63,891.21
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£35.17	55.58%	£108,909.33
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£35.17	67.63%	£117,342.89
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£376.89	332.76%	£302,931.48
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£362.42	422.07%	£365,448.02
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£362.42	31.79%	£92,252.37
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£46.75	-2.20%	£68,462.34
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£46.75	-14.92%	£59,554.14
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£9.96	-22.25%	£54,426.23
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£102.95	2.16%	£71,514.34
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£76.33	-3.91%	£67,259.57
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£44.81	-52.96%	£32,931.45
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£175.62	-35.85%	£44,907.40
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£219.02	36.20%	£95,338.60
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£476.32	71.43%	£120,001.44
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£476.32	35.78%	£95,049.46
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£476.32	-13.60%	£60,479.60
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£513.76	1,556.22%	£1,159,355.28
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£24.60	-1.64%	£68,851.91
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£3,030.00	13.14%	£79,200.90
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£643.59	2,048.16%	£1,503,715.07
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£1,020.84	39.59%	£97,710.75
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,552.00	-23.40%	£53,622.90
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£1.96	-95.47%	£3,169.32
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£877.60	57.56%	£110,290.84
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£5.29	277.86%	£264,500.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.52	-50.63%	£34,558.20
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£2.93	52.60%	£106,822.92
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.71	-31.54%	£47,923.08
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£27.76	84.45%	£129,116.28
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.21	-98.22%	£1,246.88
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£8.15	-23.26%	£53,719.39
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£6.00	-46.67%	£37,333.33
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£44.10	46.61%	£102,626.33
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£40.87	-63.50%	£25,548.31
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£399.30	18.80%	£83,162.75
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£6.51	-48.54%	£36,023.72
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£258.60	24.63%	£87,238.56
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£258.60	-5.34%	£66,259.15
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.73	-97.21%	£1,951.92
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£60.00	-46.43%	£37,500.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£60.00	16.50%	£81,553.40
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£66.94	283.17%	£268,219.83
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£3.91	-86.97%	£9,123.33
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.98	0.76%	£70,531.65

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.